| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 06/30/2005 | WO2005058321A1 USE OF METABOTROPIC GLUTAMATE RECEPTOR 5 (mGLuR5) ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS. |
| 06/30/2005 | WO2005058299A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/30/2005 | WO2005032493A8 Amide compounds as ion channel ligands and uses thereof |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | WO2004085388A3 Cyclic protein tyrosine kinase inhibitors |
| 06/30/2005 | US20050143579 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143405 Dipeptidyl peptidase inhibitors that lower plasma glucose; treatment and prophylaxis of diabetes, non-insulin dependent diabetes; 2-amino-3aminomethyl-4-phenylpyridines |
| 06/30/2005 | US20050143385 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/30/2005 | US20050143379 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | US20050139257 Photochemicaly stable amphiphilic transition metal complexes to improve the efficiency, durability and stability of the dye sensitized nanocrystalline solar cell |
| 06/30/2005 | CA2550074A1 Novel chelating agents and highly luminescent and stable chelates and their use |
| 06/30/2005 | CA2550012A1 Urea derivative, process for producing the same and use |
| 06/30/2005 | CA2549825A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549098A1 Hiv protease inhibiting compounds |
| 06/30/2005 | CA2548793A1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | CA2548657A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | CA2548571A1 Diacylhydrazine derivatives |
| 06/30/2005 | CA2548152A1 Compounds for treatment of cell proliferative diseases |
| 06/30/2005 | CA2547600A1 Novel herbicides |
| 06/29/2005 | EP1548007A1 2-Pyridinylethylcarboxamide derivatives and their use as fungicides |
| 06/29/2005 | EP1548006A1 Synthesis of tetraazapentamethine derivatives, keratin fibers dyeing process which uses such synthesis |
| 06/29/2005 | EP1548005A1 Process for producing 2-substituted pyridine derivative |
| 06/29/2005 | EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 06/29/2005 | EP1547596A1 Medicinal composition and method for treating malignant tumor and utilization thereof |
| 06/29/2005 | EP1547590A1 Melanin extinguisher |
| 06/29/2005 | EP1546425A2 Method for producing a moulded body from sintered steel |
| 06/29/2005 | EP1546284A1 Reactive dendrimers |
| 06/29/2005 | EP1546133A2 N-substitute-2-oxodihydropyridine derivatives as npy antagonists |
| 06/29/2005 | EP1546129A1 Substituted pyridine derivatives as antitumor agent |
| 06/29/2005 | EP1546117A2 Protein kinase inhibitors and uses thereof |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1546108A1 1,4-substituted cyclohexane derivatives |
| 06/29/2005 | EP1546107A1 Cox-2 inhibiting pyridine derivatives |
| 06/29/2005 | EP1546106A1 Process for the preparation of aryl-pyridyl compounds |
| 06/29/2005 | EP1546105A1 Novel derivatives of pyridylethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, processes for their preparation, and pharmaceutical compositions containing them |
| 06/29/2005 | EP1546104A1 Process for the preparation of pyridyl-arylsulfonic compounds |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1546086A2 Aminoalcohol derivatives |
| 06/29/2005 | EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 06/29/2005 | EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS |
| 06/29/2005 | EP0901459B1 Calcilytic compounds |
| 06/29/2005 | CN1633426A 1, 3-dihydroxy benzene derivatives and coloring agent containing the same |
| 06/29/2005 | CN1633416A Nicotinamide derivates useful as p38 inhibitors |
| 06/29/2005 | CN1633413A 20-hydroxyeicosatetraenoic acid production inhibitors |
| 06/29/2005 | CN1633412A Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 06/29/2005 | CN1633411A Compounds for modulating cell proliferation |
| 06/29/2005 | CN1633410A Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1631881A Process for synthesizing 2-chloro-5-chloromethylpyridine |
| 06/29/2005 | CN1631536A Catalyst for preparing pyridine with the aid of multiple element and its preparation |
| 06/29/2005 | CN1631144A Biocidal composition and its use |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 06/29/2005 | CN1208314C Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use |
| 06/29/2005 | CN1208295C Reduction of carbonyl compounds by silane in presence of zinc catalyst |
| 06/28/2005 | US6911677 Light sources comprising organic light emmiters between electrodes, used in displaying, electrophotography, recording, exposure, signs or optical communications; brightness; efficiency; durability |
| 06/28/2005 | US6911595 Charge transfer material, and photoelectric conversion device and photoelectric cell using same, and pyridine compound |
| 06/28/2005 | US6911563 Oxidation/hydrorefining catalysts; for production of aromatic alcohols |
| 06/28/2005 | US6911535 Biomolecule/polymer conjugates |
| 06/28/2005 | US6911477 Muscarinic receptor agonists |
| 06/28/2005 | US6911451 Phenylalanine derivatives |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911433 O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates |
| 06/23/2005 | WO2005056536A1 Antidiabetic agents which exhibit activity against ppar |
| 06/23/2005 | WO2005056530A1 Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activators |
| 06/23/2005 | WO2005056529A1 Cathepsin cysteine protease inhibitors |
| 06/23/2005 | WO2005056528A1 Carboxamide derivatives |
| 06/23/2005 | WO2005056520A1 Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy |
| 06/23/2005 | WO2005056519A1 Alpha-ketoamide derivative, and production method and use thereof |
| 06/23/2005 | WO2005056518A1 Sulfur- or oxygen-containing oxime ether compounds with biocidal activity |
| 06/23/2005 | WO2005056516A1 Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 06/23/2005 | WO2005056510A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 06/23/2005 | WO2005055928A2 Zn2+ -chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors |
| 06/23/2005 | WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 06/23/2005 | WO2005042444A3 Platinum complex and luminescent element |
| 06/23/2005 | WO2005040121A3 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 06/23/2005 | WO2005034870A3 Amide compounds and ion channel ligands and uses thereof |
| 06/23/2005 | WO2005033105A3 Vanilloid receptor ligands and their use in treatments |
| 06/23/2005 | WO2005025555A3 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 06/23/2005 | WO2005007601A3 Substituted arylthiourea derivatives useful as inhibitors of viral replication |
| 06/23/2005 | WO2005000406A3 Treatment of amyloid- and epileptogenesis-associated diseases |
| 06/23/2005 | WO2004024081A3 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 06/23/2005 | WO2002068380A8 Synthetic excitatory amino acids |
| 06/23/2005 | US20050137402 Process for preparing alkynyl-substituted aromatic and heterocyclic compounds |
| 06/23/2005 | US20050137236 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/23/2005 | US20050137212 Hppars activators |
| 06/23/2005 | US20050137200 Potassium channel modulators; antiarrhythmia agents |
| 06/23/2005 | US20050137193 Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; (2-phenylsulfonamidophenyl)-pyridinyl-methanones; N-[4-chloro-2(pyridine4-carbonyl)-phenyl]4-morpholin-4-yl-benzenesulfonamide |
| 06/23/2005 | US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels |
| 06/23/2005 | US20050137179 Potent antagonists of chemokine receptors and controls in drug screening assays; antiallergens, antiinflammatory, antifibrotic, antiarthritic, and anticarcinogenic agents; inflammatory bowel disease |
| 06/23/2005 | US20050137168 inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor; for treatment and/or prevention of arterial and venous thrombosis, deep vein thrombosis, pulmonary embolism, unstable angina pectoris, cardiac infarction, stroke |
| 06/23/2005 | US20050135737 Optical interleaver |
| 06/23/2005 | CA2552279A1 Zn2+-chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors |
| 06/23/2005 | CA2549548A1 Carboxamide derivatives |